Novel Potent Neuropeptide Y Y4 Receptor (Y4R) Partial Agonist (pK i : 8.47)

Natural flavonoid from the leaves of Glycyrrhiza uralensis

Novel Red-Emitting Fluorescent Dualsteric Probe for the Muscarinic Acetylcholine M2 Receptor

Novel FAAH inhibitor

Potent, selective, and irreversible inhibitor of fatty acid amide hydrolase (FAAH)

Novel potent partial agonist of histamine H4 receptors (H4R)

Novel potent partial agonist of histamine H4 receptors (H4R)

Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H3 and H4 Receptors, acting as a partial agonist at the hH3R [pEC50 (reporter gene) 8.77] and as an inverse agonist/antagonist at the h/mH4Rs [pIC50 (reporter gene) 8.76/7.08;

Novel subtype selective histamine H2 receptor G protein-biased agonist

Novel H2 receptor agonist, functionally stimulating human cardiac H2 receptors in vitro and in vivo

Novel H2 receptor agonist, functionally stimulating human cardiac H2 receptors in vitro and in vivo

Novel NPY Y1 Receptor Antagonist

Novel fluorescent histamine H3 receptor ligand

Novel H2 receptor agonist, functionally stimulating human cardiac H2 receptors in vitro and in vivo

Novel USP30 inhibitor, increasing Ub-TOM20 with an EC50 of 2.45 mM and inducing the maximal Ub-TOM20

Novel kidney urea transporter UT-A1 inhibitor

Novel

Quorum sensing modulator as a LasR antagonist

Non-immunosuppressive immunophilins ligand, demonstrating enhanced neuroregeneration in the peripheral nervous system and CNS

Novel Long Residence Time Superior Inhibitor of the Vasopressin V2 Receptor

Novel Mycobacterium Tuberculosis VapC-Activating Stapled Peptide, successfully penetrated Mycobacterium smegmatis cell membranes and exerted bactericidal activity at a minimum inhibitory concentration that inhibited 50% of the isolates (MIC50) < 6.25 μM

Novel potent inhibitor of FGFR4 kinase activity